National Health Investors, Inc. (NHI)
NYSE: NHI · IEX Real-Time Price · USD
62.51
+0.69 (1.12%)
Mar 28, 2024, 3:48 PM EDT - Market open
National Health Investors Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for NHI stock have an average target of 61, with a low estimate of 52 and a high estimate of 69. The average target predicts a decrease of -2.42% from the current stock price of 62.51.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NHI stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 2 | 3 |
Hold | 5 | 6 | 6 | 5 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wedbush | Wedbush | Buy Maintains $64 → $66 | Buy | Maintains | $64 → $66 | +5.58% | Mar 18, 2024 |
BMO Capital | BMO Capital | Hold → Buy Upgrades $67 | Hold → Buy | Upgrades | $67 | +7.18% | Mar 12, 2024 |
Wedbush | Wedbush | Hold → Buy Upgrades $57 → $64 | Hold → Buy | Upgrades | $57 → $64 | +2.38% | Feb 26, 2024 |
Wells Fargo | Wells Fargo | Hold → Buy Upgrades $55 → $63 | Hold → Buy | Upgrades | $55 → $63 | +0.78% | Feb 26, 2024 |
Deutsche Bank | Deutsche Bank | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +10.38% | Jan 30, 2024 |
Financial Forecast
Revenue This Year
320.36M
from 319.84M
Increased by 0.16%
Revenue Next Year
332.91M
from 320.36M
Increased by 3.92%
EPS This Year
2.84
from 3.13
Decreased by -9.41%
EPS Next Year
3.05
from 2.84
Increased by 7.57%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 341.0M | 355.0M | 342.0M | 480.8M | 520.4M |
Avg | 320.4M | 332.9M | 329.0M | 462.5M | 500.6M |
Low | 297.6M | 308.2M | 319.2M | 448.8M | 485.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 6.6% | 10.8% | 2.7% | 46.2% | 12.5% |
Avg | 0.2% | 3.9% | -1.2% | 40.6% | 8.2% |
Low | -6.9% | -3.8% | -4.1% | 36.4% | 5.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 2.98 | 3.27 | 3.26 |
Avg | 2.84 | 3.05 | 3.10 |
Low | 2.70 | 2.85 | 2.97 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -4.7% | 15.2% | 6.7% |
Avg | -9.4% | 7.6% | 1.5% |
Low | -13.9% | 0.6% | -2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.